Brain injury and neurometabolic abnormalities in systemic lupus erythematosus

Radiology

Volumn 209, Issue 1, 1998, Pages 79-84

  Friedman, Seth D ^a   Stidley, Christine A ^a   Brooks, William M ^a   Hart, Blaine L ^a   Sibbitt Jr , Wilmer L ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Brain, diseases; Brain, metabolism; Brain, MR; Lupus erythematosus; Magnetic resonance (MR), spectroscopy

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; BRAIN METABOLISM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031689196     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.209.1.9769816     Document Type: Article

References (40)

1. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994; 20:129-158.
2. Bell CL, Partington C, Robbins M, Graziano F, Turski P, Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus: correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 1991; 34:432-441.
3. Chinn RJS, Wilkinson ID, Hall-Craggs MA, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40:36-46.
4. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging: relationship to anticardiolipin antibody. J Rheumatol 1994; 21: 87-90.
5. Jacobs L, Kinkel PR, Costello PB, et al. Central nervous systemic lupus erythematosus: the value of magnetic resonance imaging. J Rheumatol 1988; 15:601-606.
6. Jarek M, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. AJNR 1994; 37:1609-1613.
7. McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31:159-166.
8. Sibbitt WL Jr, Haseler LH, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton magnetic resonance spectroscopy. AJNR 1994; 15: 923-928.
9. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel CG, Bankhurst AD. Magnetic resonance and CT imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 1989; 48:1014-1022.
10. Stimmler MM, Coletti PM, Quismorio FP Jr. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22:335-349.
11. Sibbitt WL Jr, Sibbitt RR. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 1993; 19:851-868.
12. Brooks WM, Sabet A, Sibbitt WL Jr, et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997; 24:2323-2329.
13. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR 1990; 11:431-439.
14. Tan EM, Cohen AS, Fries JF, et al. 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-1277.
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
16. Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993; 20:657-660.
17. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39:363-369.
18. Griffey RH, Flamig DP. VAPOR for solvent-suppressed, short echo, volume localized proton spectroscopy. J Magn Reson 1990; 88:161-166.
19. Duyn JH, Griffen J, Sobering G, van Zijl PCM, Moonen CTW. Multisection proton spectroscopy imaging of the brain. Radiology 1993; 188:277-282.
20. Sibbitt WL Jr, Haseler LJ, RR Griffey, Friedman S, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined by proton MR spectroscopy. AJNR 1997; 18:1271-1277.
21. Alger JR, Symko SC, Bizzi A, Posse S, DesPres DJ, Armstrong MR. Absolute quantitation of short TE brain 1H-MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 1993; 17:191-199.
22. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy: comparison between sequences using short and long echo times. Invest Radiol 1997; 32:485-495.
23. Bentson J, Rezon M, Winters J, et al. Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr 1978; 2:16-23.
24. Ostrov SG, Quencer RM, Gaylis MB, Altman RD. Cerebral atrophy in systemic lupus erythematosus: steroid- or disease-induced phenomenon? AJNR 1982; 3:21-23.
25. Funata N. Cerebral vascular changes in systemic lupus erythematosus. Bull Tokyo Med Dent Univ 1979; 26:91-112.
26. Ellison D, Gatter K, Heryet A, Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol 1993; 46:37-40.
27. Shiozawa S, Kuroki Y, Kim M, et al. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992; 35:417-422.
28. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine 1968; 47:337-369.
29. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathological findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979; 8:212-221.
30. Hanly JG, Walsh NMG, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19:732-741.
31. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988; 23:380-384.
32. Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989; 13:23-31.
33. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13:981-989.
34. Ross BD, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10:191-247.
35. Hugg JW, Duijn JH, Matson GB, et al. Elevated lactate and alkalosis in chronic-human brain infarction observed by H-1 and P-31 MR spectroscopic imaging. J Cereb Blood Flow Metab 1992; 12:734-744.
36. Husted CA, Goodin DS, Hugg JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo P31 and 1H spectroscopic imaging. Ann Neurol 1994; 36:157-165.
37. Davie CA, Hawkins CP, Barker GJ, Tofts PS, Miller DH, McDonald WI. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117:49-58.
38. Sappey-Marinier D, Calabrese G, Hetherington HP, et al. Proton magnetic resonance spectroscopy of human brain: application to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 1992; 26:313-327.
39. Golstein M, Meyer O, Bourgeois P, et al. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Clin Exp Rheumatol 1993; 11:373-379.
40. Hughson MD, McCarty GA, Sholer CM, Brumback RA. Thrombotic cerebral arteriopathy in patients with the antiphospho-lipid syndrome. Mod Pathol 1993; 6:644-653.